| VALPROATE SODIUM |
DEPAKINE 200MG-ML SOLU. |
200 |
|
16.35 |
Details |
| TEICOPLANIN |
TARGOCID 200MG VIAL+DILUENT |
200 |
|
84.25 |
Details |
| PERITONEAL DIALYSIS SOLUTION |
EXTRANEAL 7.5% w/v solution |
7.5 |
|
70.55 |
Details |
| PERITONEAL DIALYSIS SOLUTION |
EXTRANEAL 7.5% w/v solution |
7.5 |
|
70.55 |
Details |
| IXAZOMIB CITRATE |
NINLARO 4 mg Hard Capsule |
4 |
|
19914.95 |
Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE |
SEVITENSE 40/10 MG FILM COATED TABLET |
40,10 |
|
89.15 |
Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE |
SEVITENSE 20/10 MG FILM COATED TABLET |
20,10 |
|
78.20 |
Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE |
SEVITENSE 20/5 MG FILM COATED TABLET |
20,5 |
|
63.55 |
Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE,AMLODIPINE BESILATE |
SEVITENSE PLUS 40/10/12.5 MG FILM COATED TABLET |
40,12.5,10 |
|
105.55 |
Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE,AMLODIPINE BESILATE |
SEVITENSE PLUS 40/5/25 MG FILM COATED TABLET |
40,25,5 |
|
94.3 |
Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE,AMLODIPINE BESILATE |
SEVITENSE PLUS 40/10/25 MG FILM COATED TABLET |
40,25,10 |
|
105.55 |
Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE,AMLODIPINE BESILATE |
SEVITENSE PLUS 40/5/12.5 MG FILM COATED TABLET |
40,12.5,5 |
|
94.3 |
Details |
| OLMESARTAN MEDOXOMIL,HYDROCHLOROTHIAZIDE,AMLODIPINE BESILATE |
SEVITENSE PLUS 20/5/12.5 MG FILM COATED TABLET |
20,12.5,5 |
|
73.8 |
Details |
| DICLOFENAC SODIUM |
DIVIDO 75MG DUAL RELEASE CAP |
75 |
|
45.95 |
Details |
| WARFARIN SODIUM |
COUFATEX 1 mg Tablet |
1 |
|
77.70 |
Details |
| WARFARIN SODIUM |
COUFATEX 2 mg Tablet |
2 |
|
82.80 |
Details |
| WARFARIN SODIUM |
COUFATEX 5 mg Tablet |
5 |
|
65.50 |
Details |
| IXAZOMIB CITRATE |
NINLARO 2.3 mg Hard Capsule |
2.3 |
|
11947.4 |
Details |
| MONTELUKAST SODIUM |
EMCAST 10 MG |
10 |
|
71.45 |
Details |
| VENLAFAXINE HYDROCHLORIDE |
VENAXINE XR 75 MG CAPSULES |
75 |
|
33.85 |
Details |
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.